Menu

Working Group

« » View all

Pre-Clinical and Clinical Sciences Workgroup Q3-2015 Update

The PCS-WG is focused on the evidence-based evaluation of translational tools that support the effective decision making to advance new agents from the pre-clinical to clinical development space. These tools represent innovative approaches to address pre-clinical issues, including pre-clinical in vitro and in vivo efficacy, pre-clinical drug safety, and toxicology, pre-clinical PK/PD analyses involving the use of appropriate biomarkers, pre-clinical drug metabolism, drug interaction potential and pharmaceutical profiles. These tools may be submitted to regulatory authorities for regulatory review and/or qualification as appropriate. The PCS-WG also addresses other issues as pharmaceutics, clinical PK/PD analyses of concentration vs. pharmacologic response data from clinical studies.

3Q2015 Progress:

« » View all